Lila Sciences
Lila Sciences is hiring Automation Engineers for the AI Science Factory to operate and improve its automated platform for drug discovery and bioengineering. The role involves troubleshooting equipment, driving continuous improvement, and coordinating with multidisciplinary teams to ensure system reliability and throughput. Engineers will work on-site in Cambridge, MA, on either a first or second shift schedule.
Company Size
1-10 employees
Lila Sciences is building a scientific superintelligence platform and autonomous labs for life, chemical, and materials sciences. They place AI at the center of discovery—combining advanced models, autonomous workflows, and lab automation to rapidly generate, execute, and validate experiments at scale. Their mission is to expand human knowledge and accelerate breakthroughs to tackle some of humankind’s greatest challenges.
Lila Sciences adds Nvidia-backed $115M to series A, bringing total haul to $350M
Oct 14, 2025
Exclusive: AI lab Lila Sciences tops $1.3 billion valuation with new Nvidia backing
Oct 14, 2025
Open for business: Lila closes series A at $350M, welcomes first AI customers
Oct 14, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lila Sciences.
Lila Sciences raises $350M to build scientific superintelligence platform
Oct 16, 2025
Senior Lab Automation Engineer
Relation Therapeutics
Team Lead of Automation Core, Engineering - Lab Automation
Roche
Associate Principal Scientist, Biomarker Discovery Automation & Engineering, Multi-omics
MSD
Research Senior Scientist AI/ML Orchestration and Operationalization
Takeda Pharmaceutical Company Limited
Advisor - Lab Automation Scientist
Eli Lilly and Company
Senior AI Scientist – Hit Discovery and Protein Sciences
AstraZeneca